Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 25, 2015 10:40 AM ET

Pharmaceuticals

Company Overview of Pfizer Limited

Company Overview

Pfizer Limited, a biopharmaceutical company, engages in discovering, developing, and providing medicines, vaccines, and consumer healthcare products for people in the United Kingdom and internationally. It offers non-prescription medicines, vitamins and nutritional products, prescription medicines, over-the-counter products, and counterfeit medicines. The company was founded in 1952 and is based in Walton on the Hill, United Kingdom. Pfizer Limited operates as a subsidiary of Pfizer Inc.

Walton Oaks

Dorking Road

Walton on the Hill,  KT20 7NS

United Kingdom

Founded in 1952

Phone:

44 13 0461 6161

Fax:

44 13 0461 6221

Key Executives for Pfizer Limited

Managing Director and Head of Global Innovative Pharmaceutical Business Uk
Head of Business Development of Health Solutions UK
Medical Director
Commercial Account Director
Compensation as of Fiscal Year 2014.

Pfizer Limited Key Developments

Pfizer Wins GBP 431.2 Million Multiple Awardees Contract for Supplying Proprietary Pharmaceuticals

Pfizer Ltd. won a GBP 431.2 Million multiple awardees contract award from The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health) for the supply of proprietary pharmaceuticals (Contract Award Notice No.: 2015/S 073-128966).

Pfizer UK Appoints Erik Nordkamp as New Managing Director and Head of Global Innovative Pharmaceutical Business UK

Erik Nordkamp has been appointed Managing Director and Head of Global Innovative Pharmaceutical business UK, taking over from Jonathan Emms who has been appointed as Global Marketing Lead for Pfizer's Global Established Pharmaceutical business. Jonathan has successfully led Pfizer's UK business for three years, and in the past year has also served as ABPI President. In both roles, Jonathan has been at the forefront of discussions with Government, the NHS and NICE on improving access to innovative medicines for UK patients.

Pfizer Limited (UK) Presents at DigiPharm & Mobile Pharma Europe, Oct-10-2013 03:30 PM

Pfizer Limited (UK) Presents at DigiPharm & Mobile Pharma Europe, Oct-10-2013 03:30 PM. Venue: The Tower Hotel, London, United Kingdom. Speakers: Dave Pinnington, Digital Marketing Director EUCAN.

Similar Private Companies By Industry

Company Name Region
Glenmark Generics (Europe) Limited Europe
Flynn Pharma (Holdings) Ltd. Europe
Therakind Limited Europe
Janssen-Cilag Limited Europe
Enterprise Therapeutics Ltd Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pfizer Limited, please visit www.pfizer.co.uk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.